Literature DB >> 27604734

Experimental Models Combining Traumatic Brain Injury and Hypoxia.

Eric P Thelin1,2.   

Abstract

Traumatic brain injury (TBI) is one of the most common causes of death and disability, and cerebral hypoxia is a frequently occurring harmful secondary event in TBI patients. The hypoxic conditions that occur on the scene of accident, where the airways are often obstructed or breathing is in other ways impaired, could be reproduced using animal TBI models where oxygen delivery is strictly controlled throughout the entire experimental procedure. Monitoring physiological parameters of the animal is of utmost importance in order to maintain an adequate quality of the experiment. Peripheral oxygen saturation, O2 pressure (pO2) in the blood, or fraction of inhaled O2 (FiO2) could be used as goals to validate the hypoxic conditions. Different models of traumatic brain injury could be used to inflict desired injury type, whereas effects then could be studied using radiological, physiological and functional tests. In order to confirm that the brain has been affected by a hypoxic injury, appropriate substances in the affected cerebral tissue, cerebrospinal fluid, or serum should be analyzed.

Entities:  

Keywords:  Animal model; CCI; Controlled cortical impact; Fluid percussion; Hypoxia; Hypoxic; Monitoring; Oxygen saturation; Posttraumatic hypoxia; Traumatic brain injury; Ventilation

Mesh:

Year:  2016        PMID: 27604734     DOI: 10.1007/978-1-4939-3816-2_26

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Hypoxia and Alpha-Synuclein: Inextricable Link Underlying the Pathologic Progression of Parkinson's Disease.

Authors:  Mengyuan Guo; Xunming Ji; Jia Liu
Journal:  Front Aging Neurosci       Date:  2022-07-26       Impact factor: 5.702

Review 2.  Technical Feasibility and Physiological Relevance of Hypoxic Cell Culture Models.

Authors:  Jiri Pavlacky; Jan Polak
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-21       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.